This article is a correction to:
High Follicle-Stimulating Hormone Level Associated With Risk of Rheumatoid Arthritis and Disease Activity
Xianhui Zhang
Pengyan Qiao1†
Jie Pan
Fengping Wu- 1Department of Rheumatology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China
- 2Department of Biomedical Engineering, Duke University Pratt School of Engineering, Durham, NC, United States
- 3Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, United States
- 4School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China
A Corrigendum on
High follicle-stimulating hormone level associated with risk of rheumatoid arthritis and disease activity
by Zhang X, Qiao P, Guo Q, Liang Z, Pan J, Wu F, Wang X and Zhang L (2022) Front. Endocrinol. 13:862849. doi: 10.3389/fendo.2022.862849
In the published article, there was an error in affiliation 1. Instead of “Department of Rheumatology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Tongji Medical College, Huazhong University of Science and Technology, Taiyuan, China”, it should be “Department of Rheumatology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China”.
In the published article, there was also an error regarding the affiliation for Liyun Zhang. Instead of having affiliation 5 Department of Rheumatology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences; Tongji Shanxi Hospital, Tongji Medical College, Huazhong University of Science and Technology, Taiyuan, China, they should have affiliation 1 Department of Rheumatology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China. Affiliation 5 has now been removed.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: FSH, menopause, rheumatoid arthritis, disease activity, sex hormones
Citation: Zhang X, Qiao P, Guo Q, Liang Z, Pan J, Wu F, Wang X and Zhang L (2023) Corrigendum: High follicle-stimulating hormone level associated with risk of rheumatoid arthritis and disease activity. Front. Endocrinol. 14:1238584. doi: 10.3389/fendo.2023.1238584
Received: 12 June 2023; Accepted: 14 June 2023;
Published: 23 June 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Zhang, Qiao, Guo, Liang, Pan, Wu, Wang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Liyun Zhang, 1315710223@qq.com
†These authors have contributed equally to this work and share first authorship